Intra-tumor Injection of Drug-eluting Microspheres
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 1
Summary
- Conditions
- Hepatocellular Carcinoma
- Solid Tumor, Adult
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 99 years
- Gender
- Both males and females
Description
Assessing side effects and treatment efficacy after injection of drug-eluting microspheres into malignant tumors
Assessing side effects and treatment efficacy after injection of drug-eluting microspheres into malignant tumors
Tracking Information
- NCT #
- NCT04770207
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Zhenfeng Zhang, MD, PhD Second Affiliated Hospital of Guangzhou Medical University